openPR Logo
Press release

Europe Platelet Rich Plasma (PRP) Market Poised for Steady Growth in the Future

11-14-2016 08:09 AM CET | Health & Medicine

Press release from: Future Market Insights

Europe Platelet Rich Plasma (PRP) Market Poised for Steady

The market for platelet rich plasma (PRP) Europe is expected to reach US$ 37.5 Mn in 2016, up from US$ 35.3 Mn in 2015. Adoption of platelet rich plasma in treating musculoskeletal injuries, including tennis elbow, Achilles tendinopathy, and plantar fasciitis, will continue to drive revenues. PRP therapy is also gaining traction in treating sports-related and geriatric injuries, owing to its minimally invasive procedure and quicker recovery time.

By product type, PRP kits will continue to outsell instruments, accounting for over 75% revenue share of the market in 2016. Among the various platelet rich plasma kits, autologous kits will account for the highest demand on the basis of blood type, representing a market value worth US$ 24.2 Mn. P-PRF kits—valued at US$ 10 Mn in 2015—will witness the highest growth by end-product type, increasing at 8.6% in 2016.

By application, adoption of PRP therapy will continue to remain highest in the treatment of knee and elbow injuries. While knee application segment revenues will grow by 7.2%, elbow application segment revenues are projected to grow by 6.3%. Use of PRP therapy in the treatment of ever-increasing incidences of osteoarthritis and tennis elbow will gain further traction in 2016 and beyond.

PRP revenues in the UK—the largest market in Europe—will grow by 7.3% in 2016, an increase of 0.20% from the 7.1% growth in 2015. High prevalence of sports-related incidents in the U.K., combined with high awareness about the benefits of PRP therapy among healthcare community and patients, will continue to fuel the growth of the market in the country.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-eu-1599

France will maintain its position as the second largest market for PRP in Europe, growing by 6.5% in terms of revenues in 2016. France is home to subsidiaries and distributors of several PRP players, such as Biomet, Inc., DePuy Synthes, Inc., and Stryker Corporation and a range of highly innovative products are available in the market.

Johnson & Johnson Inc. and Stryker Corporation are the established players in the Europe PRP market. Johnson & Johnson’s PEAK™ Platelet Rich Plasma System and Stryker Corporation’s RegenKit THT Autologous Platelet-rich Plasma (A-PRP) will continue to witness sizeable sales in 2016. Arthrex - Arthrex Angel System™ from Arthrex Inc. and GPS® III Platelet Separation System by Zimmer Biomet Holdings Inc. will also account for substantial revenue share of the Europe PRP market.

Send An Enquiry@ http://www.futuremarketinsights.com/askus/rep-eu-1599

Long-term Outlook: The PRP market in Europe is expected to increase at a CAGR of 6.6% during the forecast period 2016-2024. The UK will continue to be at the forefront of overall demand, with France and Germany accounting for sizeable market share. While FMI maintains a positive outlook on the Europe PRP market, challenges, including lack of standardisation in preparation and dosage of autologous blood concentrate, and uncertainty about therapy efficacy can impede growth during the forecast period.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Press@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Europe Platelet Rich Plasma (PRP) Market Poised for Steady Growth in the Future here

News-ID: 382036 • Views:

More Releases from Future Market Insights

Workstation Software Market to Soar to USD 43.9 Billion by 2035, Fueled by 3D Modeling and VR Innovation
Workstation Software Market to Soar to USD 43.9 Billion by 2035, Fueled by 3D Mo …
Rising Demand for Workstation Software Across Industries The global workstation software market is set for robust growth, driven by increasing demand for advanced visualization, simulation, and design tools across industries such as manufacturing, architecture, media, and entertainment. Valued at USD 14.8 billion in 2025, the market is projected to reach USD 43.9 billion by 2035, registering a compound annual growth rate (CAGR) of 11.5%. This surge reflects the rising complexity of
Bean Flour Market Set for Robust Growth in the USA at 6.27% CAGR Through 2035
Bean Flour Market Set for Robust Growth in the USA at 6.27% CAGR Through 2035
The global bean flour market is entering a period of remarkable expansion, driven by surging demand for plant-based nutrition and gluten-free alternatives. Analysts forecast the market to grow from USD 5,075.3 million in 2025 to USD 9,262.0 million by 2035, reflecting a CAGR of 6.2%. This trajectory highlights an unparalleled opportunity for manufacturers to address evolving consumer preferences while enhancing sustainability and profitability. As the world shifts towards cleaner diets and
Blueberry Ingredient Market Set to Soar with 6.27% Growth in the USA by 2035
Blueberry Ingredient Market Set to Soar with 6.27% Growth in the USA by 2035
The blueberry ingredient industry has firmly established itself as a cornerstone of the functional foods, nutraceuticals, and natural flavoring sectors. Analysts project the market valuation to reach approximately USD 2.8 billion by 2025, with a robust CAGR of 6.5% forecasted from 2025 to 2035. This growth is being fueled by the escalating demand for clean-label products, plant-based formulations, and functional solutions across the food, beverage, and cosmetic industries. Click Here for
Activated Cake Emulsifier Market Set for 6.27% Growth in the USA, Poised to Transform Baking Innovation by 2035
Activated Cake Emulsifier Market Set for 6.27% Growth in the USA, Poised to Tran …
The activated cake emulsifier market is entering a transformative phase, driven by evolving consumer preferences toward premium, high-quality bakery products. Estimated to reach USD 1,343.2 million in 2025, the market is projected to achieve USD 2,360.5 million by 2035, representing a robust 5.8% CAGR over the next decade. This growth offers a strategic opportunity for manufacturers to meet rising consumer demands while future-proofing operations through innovation, regional customization, and sustainability. Click

All 5 Releases


More Releases for PRP

Therapeutic PRP Tubes Market to Witness Growth at a 6.6% CAGR by 2031 | Regen La …
QYResearch A newly published report titled "Global Therapeutic PRP Tubes Market 2025 is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Therapeutic PRP Tubes market. For instance, the market dynamics section digs deep into the
Global PRP Centrifuges Market Research Report 2023-2029
Global Leading Market Research Publisher QYResearch announces the release of its lastest report "Global PRP Centrifuges Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application". Based on historical analysis (2018-2022) and forecast calculations (2023-2029), this report provides a comprehensive analysis of the global PRP Centrifuges market, including market size, share, demand, industry development status, and forecasts for the next few years. Provides advanced statistics
Latest Study on Platelet Rich Plasma (PRP) Market Future Growth Predictions and …
The Global Platelet Rich Plasma (PRP) Market 2019-2026 increase in the number of orthopedic surgeries and sports injuries and rise in the number of cosmetic surgeries are driving the growth of the market. However, high cost of devices & therapy will limit the market growth. The Global Platelet Rich Plasma (PRP) Market 2019 report includes Platelet Rich Plasma (PRP) Market Revenue, market Share, industry volume, and Trends, Growth aspects. Growing prevalence
Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% …
New Study Report On "Platelet Rich Plasma (PRP) Market is expected to grow at a CAGR of roughly 13.3% | Analysis By PRP Type (P-PRP, L-PRP, L-PRF), By Players (DePuy Synthes, Stryker...), By Surgery (Orthopedic, Cosmetic, General...) & Region, Size & Forecast To 2023" The worldwide market for Platelet Rich Plasma (PRP) is expected to grow at a CAGR of roughly 13.3% over the next five years, will reach 400 million
Platelet Rich Plasma Market By PRP Type (Pure-PRP, Leucocyte Rich PRP, Pure Plat …
Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its
Platelet Rich Plasma (PRP) Market Forecast 2017-2021
Platelet rich plasma (PRP) market has witnessed appreciable growth due to a growing number of devices being FDA approved in recent years; however the therapeutics market is anticipated to have an uncertain future, even as non-approved therapeutic applications flourish. Although various platelet rich plasma isolation devices have received 510(k) clearance, platelet rich plasma has not been approved for direct injection or implant without prior mixing with the bone graft materials.